Search
for
Sort by
Research 151–180 of 1000+
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Janus kinase inhibitors for alopecia areata: A narrative review
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Baricitinib: A Review in Severe Alopecia Areata
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Alopecia areata: current concepts
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case–Control Study
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Immunopathogenesis and Experimental Models of Alopecia Areata: From Mechanistic Insights to Translational Platforms
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata